Strides Arcolab Ltd's, US subsidiary Strides Inc and STADA Pharmaceuticals Inc, the US subsidiary of STADA Arzneimittel AG, have signed a development and supply agreement for a prescription generic drug product
for the US market.
The product will be developed and manufactured by Strides Inc at its US soft gelatin manufacturing facility exclusively for STADA's sale in the US, Stride informed the Bombay Stock Exchange on Thursday.
© Copyright 2025 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.
